ROCKVILLE, Md.--(BUSINESS WIRE)--June 11, 2007--Emergent
BioSolutions Inc. (NYSE:EBS) announced today that it will hold its
Annual Meeting of Stockholders on Thursday June 14, 2007 beginning at
10:00 am Eastern Time at the Hyatt Regency Bethesda, One Metro Center,
7400 Wisconsin Avenue, Bethesda, Maryland.
Interested parties may listen to the Annual Meeting via conference
call by dialing either 1-866-700-0161 in the U.S. or +1-617-213-8832
outside the U.S. No Passcode is required for the live call. Interested
parties may also access a webcast of the Annual Meeting by visiting
the Emergent BioSolutions website at www.emergentbiosolutions.com. A
replay of the webcast of the Annual Meeting will be available under
the "Investors" section of the company's website until June 28, 2007.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company
dedicated to one simple mission--to protect life. We develop,
manufacture and commercialize immunobiotics, consisting of vaccines
and therapeutics that assist the body's immune system to prevent or
treat disease. Our biodefense business focuses on immunobiotics for
use against biological agents that are potential weapons of
bioterrorism and biowarfare. Our marketed product, BioThrax(R)
(Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S.
Food and Drug Administration for the prevention of anthrax infection.
Our commercial business focuses on immunobiotics for use against
infectious diseases and other medical conditions that have resulted in
significant unmet or underserved public health needs. More information
on the company is available at www.emergentbiosolutions.com.
CONTACT: Emergent BioSolutions Inc.
Robert G. Burrows
Vice President, Corporate Communications
SOURCE: Emergent BioSolutions Inc.